IMDX

Insight Molecular Diagnostics Inc. Common Stock

3.95

USD

+0.04

+1.02%

Sep 24, 15:59 UTC -4

Closed

Pre-Market

3.94

-0.01

-0.13%

IMDX Earnings Reports

Positive Surprise Ratio

IMDX beat 16 of 43 last estimates.

37%

Next Report

Date of Next Report

Nov 09, 2026

Estimate for Q3 26 (Revenue/ EPS)

$249.08K

-$0.24

Implied change from Q2 26 (Revenue/ EPS)

+4.22%

-22.58%

Implied change from Q3 25 (Revenue/ EPS)

-4.20%

-29.41%

Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue

On Aug 10, 2026, IMDX reported earnings of -0.31 USD per share (EPS) for Q2 26, missing the estimate of -0.24 USD, resulting in a -24.45% surprise. Revenue reached 239.00 thousand, compared to an expected 446.25 thousand, with a -46.44% difference. The market reacted with a -7.13% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 249.08 thousand USD, implying an decrease of -22.58% EPS, and increase of 4.22% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

HeartSciences Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

-$0.73

Actual

-$0.86

Surprise

-16.29%

FAQ

What were Insight Molecular Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Insight Molecular Diagnostics Inc. Common Stock reported EPS of -$0.31, missing estimates by -24.45%, and revenue of $239.00K, -46.44% below expectations.

How did the market react to Insight Molecular Diagnostics Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -7.13%, changed from $4.77 before the earnings release to $4.43 the day after.

When is Insight Molecular Diagnostics Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 09, 2026.

What are the forecasts for Insight Molecular Diagnostics Inc. Common Stock's next earnings report?

Based on 5 analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $249.08K for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.